Capstan Therapeutics, press release, Initiation of a phase 1 trial of the lead in-vivo CAR-T therapy CPTX2309 for autoimmune disease (company release)

https://www.biospace.com/press-releases/capstan-therapeutics-announces-initiation-of-phase-1-trial-of-lead-in-vivo-car-t-therapy-cptx2309-for-treating-autoimmune-disease

Authors. Capstan Therapeutics, press release

Venue. (company release)

How the Institute flags it

frontier 4 times

Cited on 4 pages

• Immune Engineering
• Nanomedicine
• RNA Medicines
• Whole Organ Regeneration